SELLAS Life Sciences Group, Inc. — Director's Dealing 2016

Apr 29, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Galena Biopharma, Inc. (GALE)
CIK: 0001390478
Period of Report: 2016-04-25

Reporting Person: GRAY MARY ANN (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-04-25	Stock Option (right to buy)	$1.4	A	200000	Acquired	2026-04-25	Common Stock (200000)	Direct

Footnotes

F1: Granted pursuant to the Issuer's 2007 Incentive Plan.

F2: This stock option vests in four equal, quarterly installments over a period of one year beginning three months after April 25, 2016.